CASE SHARING: CLINICAL EXPERIENCE OF HIGH PROTEIN WITH HMB SUPPLEMENTATION

Dr. Wong Cheuk Lik

Specialist in Endocrinology,

Diabetes & Metabolism

KEY MESSAGES

 

1. Low muscle strength is associated with an increased risk of chronic disease:26-28

2. Real case sharing:

An 85-year-old woman with longstanding diabetes (since 1993) and osteoporosis presented to the clinic for unintentional weight loss (from 50kg to 43kg) and decline in walking speed. She was short in stature (height 144cm) and lived a sedentary lifestyle.

Other major past medical history included coronary artery disease and chronic kidney disease(stage 3b) for which she was on an SGLT-2 inhibitor. She was diagnosed to have possible sarcopenia by a small calf circumference (< 33cm), elevated 5-time chair stand test (≥12secs) and borderline low handgrip strength (18kg). 

Due to fear of worsening glycemic control, she restricted both carbohydrates and protein intake in her diet. Her body weight didn't increase despite repeated counselling on diet and exercise.

  • Treatment goal: 
    • Prevent further weight loss and maintain normal body weight 
    • Prevent sarcopenia 
    • Improve muscle function and stamina 
  • Treatment strategy: 
    • Dietary counselling to increase protein intake for muscle rebuilding 
    • No approved medication available for sarcopenia 
    • Oral nutritional supplements with HMB (2 servings/day) are recommended to improve nutritional status regarding energy level and protein intake and to increase muscle mass. (Protein intake should be assessed on a case-by-case basis according to the CKD status.) 
  • Clinical outcome: 
    • After 60 days of ONS + HMB (2 servings of 1.5g CaHMB per day) intervention, the patient’s nutritional status and muscle function were significantly improved:

3. RCT evidence

HMB can stimulate the acceleration of wound healing and increase muscle strength in malnourished patients with hip fractures:29

PAST EVENTS

Footnotes:

*P < 0.05

CaHMB, calcium ß-hydroxy-ß-methyl butyrate; CKD, chronic kidney disease; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; HMB, ß-hydroxy-ß-methyl butyrate; ONS, oral nutritional supplement; QoL, quality of life; RCT, randomized controlled trial; SGLT-2, sodium-glucose cotransporter-2.

Study design: This randomized controlled study included 75 older female patients with a hip fracture admitted to orthopedic clinics. The control group received standard postoperative nutrition. The study group received an enteral product containing 3 g CaHMB, 1000 IU vitamin D, and 36 g protein, in addition to standard postoperative nutrition. Anthropometric, laboratory, wound-healing, immobilization period, and muscle strength assessments were evaluated preoperatively and on postoperative days 15 and 30.29

References:

  1. Peterson MD, et al. J Gerontol A Biol Sci Med Sci. 2017;72:1525-31.
  2. Li CI, et al. BMC Geriatr. 2015;15:11.
  3. Lopez-Jaramillo P, et al. Anatol J Cardiol. 2022;26:598–607.
  4. Ekinci O, et al. Nutr Clin Pract. 2016;31:829-35.

 

HKG.2025.58178.ENS

Order ID: #12345
Order Date: 01/05/2024
Product Product Flavour Product Quantity
Loading...

SESSION TIMEOUT

Your session is about to expire in {min} minutes and you will be logged out. Do you wish to stay logged in?
UK-N/A-2400058 (V8) | October 2024

You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.

You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.

UK-N/A-2400058 (V8) | October 2024
bookmarkbookmarkedbookmark-hover
Click here to add this page to your bookmarks.

This page has been added to your bookmark. To access your bookmark list, Click this link.